Uncovering Silent Cardiovascular Threats: The Role of Lipoprotein(a) in Heart Health

Photo by Marek Studzinski on Unsplash

When most people think about heart disease risk, they focus on familiar metrics like LDL (“bad” cholesterol), HDL (“good” cholesterol), and triglycerides-numbers that show up on routine lipid panels. But for a significant portion of the population, these tests miss a critical biomarker that can predict cardiovascular events even when other cholesterol levels are within normal ranges. This biomarker plays a unique role in the development of plaque buildup in arteries, and its presence can turn what seems like a low-risk profile into a hidden threat.

What Is This Overlooked Biomarker?

At the center of this hidden risk is a particle called lipoprotein(a), or Lp(a) for short. First identified in the 1960s, Lp(a) is a type of lipoprotein that shares similarities with LDL but has an additional protein component called apolipoprotein(a) attached to it. This extra protein gives Lp(a) distinct properties that make it particularly harmful to heart health. Unlike LDL, which is influenced by diet and exercise, Lp(a) levels are largely determined by genetics-meaning they’re set at birth and remain relatively stable throughout a person’s life.

One of the key ways Lp(a) contributes to heart disease is by promoting the formation of atherosclerotic plaques in artery walls. The apolipoprotein(a) component has a structure similar to plasminogen, a protein that helps break down blood clots. When Lp(a) accumulates in arteries, it can interfere with plasminogen’s ability to dissolve clots, increasing the risk of blood clots that can lead to heart attacks or strokes. Additionally, Lp(a) can trigger inflammation in the arterial lining, further accelerating plaque growth and instability.

Why It’s a Hidden Risk Factor

Most routine lipid panels don’t include Lp(a) testing, which means many people with elevated levels are unaware of their increased risk. Even individuals who follow a strict healthy diet, exercise regularly, and maintain normal LDL levels can have high Lp(a) and be at risk for cardiovascular events. For example, a person with an LDL level of 100 mg/dL (considered optimal) but an Lp(a) level above 50 mg/dL may have a similar risk of heart attack as someone with an LDL level of 160 mg/dL and normal Lp(a).

Another reason Lp(a) is a hidden risk is that there’s no obvious way to tell if you have elevated levels without a specific test. There are no symptoms associated with high Lp(a), so the only way to know is to ask your healthcare provider to include it in your lipid panel. This lack of awareness means that many people don’t get tested until they’ve already experienced a cardiovascular event, by which time it’s too late for preventive measures.

Who Should Get Tested for Lp(a)?

Current guidelines from organizations like the American Heart Association (AHA) recommend Lp(a) testing for certain groups of people. These include individuals with a family history of premature heart disease (heart attack or stroke before age 55 in men or 65 in women), those with personal history of heart disease or stroke despite normal LDL levels, and people with familial hypercholesterolemia (a genetic condition that causes high LDL levels). Additionally, some experts suggest testing for individuals with other risk factors like diabetes, high blood pressure, or smoking, especially if they have a family history of heart disease.

It’s important to note that Lp(a) testing isn’t necessary for everyone. For people with no family history of premature heart disease and no other risk factors, routine testing may not be recommended. However, if you have concerns about your heart health or fall into one of the high-risk groups, talking to your healthcare provider about Lp(a) testing is a good idea.

Managing Elevated Lp(a) Levels

While there’s currently no specific medication approved by the U.S. Food and Drug Administration (FDA) to lower Lp(a) levels, there are strategies to reduce the overall risk of heart disease in people with elevated Lp(a). The first step is to control other modifiable risk factors, such as maintaining a healthy diet rich in fruits, vegetables, whole grains, and lean proteins, exercising regularly for at least 150 minutes per week of moderate activity, quitting smoking, and managing high blood pressure and diabetes. These lifestyle changes can help reduce the impact of Lp(a) on heart health.

Some medications used to lower LDL levels may also have a small effect on Lp(a). For example, statins, which are commonly prescribed to lower LDL, can reduce Lp(a) levels by about 10-20%. However, this effect is not as significant as their effect on LDL, so statins are not considered a primary treatment for elevated Lp(a). Other medications, such as PCSK9 inhibitors, may also have a modest effect on Lp(a) levels, but more research is needed to determine their long-term benefits for people with high Lp(a).

In recent years, there has been growing interest in new treatments specifically targeting Lp(a). Several drugs are currently in clinical trials, including antisense oligonucleotides (ASOs) and small interfering RNAs (siRNAs), which work by reducing the production of apolipoprotein(a) in the liver. These drugs have shown promising results in lowering Lp(a) levels by up to 80% in early trials, and if approved, they could provide a new option for people with elevated Lp(a) and high risk of heart disease.

Photo by Robina Weermeijer on Unsplash

The Importance of Proactive Heart Health

Understanding the role of Lp(a) in heart disease is an important step in proactive heart health. By getting tested for Lp(a) if you’re in a high-risk group, you and your healthcare provider can develop a personalized prevention plan that addresses all of your risk factors. This may include lifestyle changes, medications, and regular monitoring to ensure that your heart health is on track.

It’s also important to remember that heart disease is a complex condition with many risk factors. While Lp(a) is an important biomarker, it’s just one piece of the puzzle. By taking a comprehensive approach to heart health-including regular screenings, healthy lifestyle habits, and open communication with your healthcare provider-you can reduce your risk of heart disease and live a long, healthy life. For those who want to learn more, exploring peer-reviewed medical journals, reputable health organizations’ websites, and consulting with a cardiologist can provide deeper insights into this biomarker and its implications for individual heart health.